ArticleIndian dermatology online journal2025
The Varying Faces of Vulvar Neoplasia.
Article in Indian dermatology online journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
abstractVulvar neoplasia is on the rise and patients often present to dermatologists with lesions of varying morphology associated with pruritus, burning sensation, or pain. Early diagnosis results in an early treatment and improved quality of life. Differentiating vulvar neoplasia and intraepithelial malignancies from benign and inflammatory conditions is imperative. Histopathology and immunohistochemistry (IHC) are helpful. Herein, we report eight women who presented with varying features. Five of them had predisposing factors- four had lichen sclerosus, and one was human immunodeficiency virus (HIV) positive. All women were diagnosed and treated promptly. Vulvar malignancies encompass both invasive vulvar squamous cell carcinoma (SCC) and its precursors, as well as other less common forms like melanoma, basal cell carcinoma, and extramammary Paget's disease. Vulvar SCC contributes to 80%-90% of vulvar malignancies. It's precursor lesions, vulvar intraepithelial neoplasia (VIN), are now classified as differentiated VIN (dVIN), low-grade squamous intraepithelial neoplasias (LSIL), and high grade squamous intraepithelial neoplasias (HSIL). VIN are of varying morphology and are diagnosed by histopathology and IHC. Dermoscopy of VIN is still evolving. Herein, we also describe the dermoscopic features of lesions encountered. Treatment is resection, wherever possible.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.